<DOC>
	<DOCNO>NCT03029039</DOCNO>
	<brief_summary>Sepsis represent serious public health issue characterize complex inflammatory response . In addition hemostatic role , platelet display inflammatory function secrete variety immunomodulatory factor interact circulate immune cell . The investigator postulate , severe sepsis , platelets become activated release amount different soluble inflammatory molecule contribute sepsis-associated inflammation . First , investigator propose ass whether severe sepsis impairs ability platelet release soluble CD40L ( sCD40L ) , powerful platelet-derived immunomodulatory molecule , ICU patient S. aureus document infection , ICU patient document infection involve bacterial specie , compare ICU patient inflammation noninfectious origin healthy blood donor . Then , investigator wish ass whether bacterial specie affect release platelet sCD40L extensive screening platelet soluble factor , investigator propose set profile inflammatory molecule associate type infection . Finally , investigator analyze platelet ' activation state association circulate immune , accord type infection . Therefore , project expect assess extent platelet inflammatory function super-activated severe sepsis identify new platelet-related biomarkers sepsis .</brief_summary>
	<brief_title>Platelet-associated Inflammation Severe Sepsis</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<criteria>Inclusion criterion Common inclusion criterion ICU patient : Signed informed consent , Patient affiliate entitle social security , age 18 year , Criteria blood donor voluntary : weigh 50 kg Criteria severe sepsis group : Sepsis failure least one organ , severe sepsis le 72 hour , sepsis bacteria S. aureus , S. pneumoniae E. coli . Criteria uninfectious inflammatory syndrome group : patient operate since less 24 hour hip knee surgery , Absence systemic infection Exclusion Criteria failure participate study Patients aspirin treatment continue throughout severe sepsis Patients appropriate antibiotic therapy 72 hour Patients platelet transfusion week inclusion 72 hour surgical gesture occurrence sepsis Patients platelet account less 30 000 per cubic millimeter day sample Patients severe sepsis surgical gesture previous week inclusion All clinical sequela biological selection pregnant woman Patients treatment platelet aggregation continue throughout severe sepsis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Platelet</keyword>
	<keyword>severe sepsis</keyword>
	<keyword>inflammation</keyword>
	<keyword>S. aureus</keyword>
	<keyword>biomarkers</keyword>
</DOC>